期刊文献+

分化型甲状腺癌术后颈淋巴结持续或复发治疗进展 被引量:3

Progress in the treatment of persistent or recurrent cervical lymph nodes of postoperative differentiated thyroid carcinoma
原文传递
导出
摘要 颈淋巴结复发是分化型甲状腺癌复发中最主要的一部分,其治疗的主要方案为再手术治疗。近年来一些如主动监测、射频消融、放射性碘治疗等代替手术治疗的方案逐渐被提出。部分治疗手段的效果及并发症仍有争议,再手术仍是首选的治疗方式,再术后的放射性碘治疗可能不会改善病人的预后,射频消融应仅限应用于不适合再次手术治疗的病人。 Cervical lymph node recurrence is the most important part of the recurrence of differentiated thyroid cancer,and the main treatment is reoperation.In recent years,some alternative treatments such as active monitoring,radiofrequency ablation and radioiodine therapy have gradually been proposed.The effects and complications of these treatment methods are still controversial.Reoperation is still the preferred treatment.Radioiodine therapy after reoperation may not improve the prognosis of patients.Radiofrequency ablation should only be applied to patients who are not suitable for reoperation.
作者 曲幽 张浩 QU You;ZHANG Hao(Department of Thyroid Surgery,the First Hospital of China Medical University,Shenyang 110001,China)
出处 《中国实用外科杂志》 CAS CSCD 北大核心 2021年第8期940-944,共5页 Chinese Journal of Practical Surgery
基金 辽宁省自然科学基金项目(No.201805300907)。
关键词 甲状腺癌 复发 持续 再手术 放射性碘治疗 射频消融 thyroid cancer recurrence persistent reoperation radioiodine therapy radiofrequency ablation
  • 相关文献

参考文献5

二级参考文献64

  • 1Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016 [ J ]. CA Cancer J Clin,2016,66( 1 ) :7-30.
  • 2Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015[ J]. CA Cancer J Clin,2016,66(2) :115-132.
  • 3Sherman SI. Thyroid carcinoma [ J ]. Lancet, 2003,361 ( 9356 ) : 501-511.
  • 4MazzafexTi EL, Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer[ J l. Am J Med, 1994,97(5 ) :418-428.
  • 5Hay ID, Thompson GB, Grant CS, et al. Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999) : tempo- rat trends in initial therapy and long-term outcome in 2444 consecu- tively treated patients[J]. World J Surg,2002,26(8) :879-885.
  • 6Tufano RP, Clayman G, Heller KS, et al. Management of recur- rent/persistent nodal disease in patients with differentiated thyroid cancer: a critical review of the risks and benefits of surgical inter- vention versus active surveillance [ J ]. Thyroid ,2015,25 ( 1 ) : 15-27.
  • 7Haugen BR, Alexander EK, Bible KC, et at. 2015 Americma Thyroid Association Managenlent Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differenti- ated q3tyroid Cancer[J]. Thyroid, 2016,26 ( 1 ) :1-133.
  • 8Machens A, Hinze R, Thomusch O, et al. Pattern of nodal metas- tasis for primary and reoperative thyroid cancer[J]. World J Stag, 2002,26( 1 ) :22-28.
  • 9Shah MD, Harris LD, Nassif RG, et at. Efficacy and safety of cen- tral compartment neck dissection for recurrent thyroid carcinoma[J]. Arch Otolaryngol Head Neck Surg,2012,138 ( 1 ) :33-37.
  • 10Patron V, Hitler M, Bedfert C, et al. Occult lymph node metasta- ses increase locoregional recurrence in differentiated thyroid carci- nmna [J]. Ann Otol Rhinol Laryngol, 2012,121 ( 5 ) :283-290.

共引文献370

同被引文献28

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部